Search Results - "Jossy van den Boogaard"

Refine Results
  1. 1
  2. 2

    Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients by TOSTMANN, Alma, MTABHO, Charles M, SEMVUA, Hadija H, VAN DEN BOOGAARD, Jossy, KIBIKI, Gibson S, BOEREE, Martin J, AARNOUTSE, Rob E

    Published in Antimicrobial Agents and Chemotherapy (01-07-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic by Heijmink, Lisanne, Tönis, Juul, Gilhuis, Niek, Gerkema, Maartje, Hart, Lotte, Raven, Stijn, van den Boogaard, Jossy, Hofhuis, Agnetha, van den Hof, Susan, Visser, Olga

    Published in Epidemiology and infection (15-11-2022)
    “…During 6 weeks in February–March 2021, the Dutch municipal health service Utrecht studied the epidemiological effects on test incidence and the detection of…”
    Get full text
    Journal Article
  4. 4

    High Incidence of Active Tuberculosis in Asylum Seekers from Eritrea and Somalia in the First 5 Years after Arrival in the Netherlands by van den Boogaard, Jossy, Slump, Erika, Schimmel, Henrieke J, van der Hoek, Wim, van den Hof, Susan, de Vries, Gerard

    Published in Emerging infectious diseases (01-04-2020)
    “…Three quarters of tuberculosis (TB) patients in the Netherlands are foreign-born; 26% are from Eritrea or Somalia. We analyzed TB incidence rates in asylum…”
    Get full text
    Journal Article
  5. 5

    Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis by van den Boogaard, Jossy, de Gier, Brechje, de Oliveira Bressane Lima, Priscila, Desai, Shalini, de Melker, Hester E., Hahné, Susan J.M., Veldhuijzen, Irene K.

    Published in Vaccine (05-02-2021)
    “…•One and two doses of rubella containing vaccines (RCV) are highly immunogenic for a long period of time.•RCV are effective in preventing rubella and CRS.•RCV…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study by VAN DEN BOOGAARD, Jossy, LYIMO, Ramsey A, BOEREE, Martin J, KIBIKI, Gibson S, AARNOUTSE, Rob E

    Published in Bulletin of the World Health Organization (01-09-2011)
    “…To assess adherence to community-based directly observed treatment (DOT) among Tanzanian tuberculosis patients using the Medication Event Monitoring System…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective by Lyimo, Ramsey A, de Bruin, Marijn, van den Boogaard, Jossy, Hospers, Harm J, van der Ven, André, Mushi, Declare

    Published in BMC public health (30-08-2012)
    “…To design effective, tailored interventions to support antiretroviral therapy (ART) adherence, a thorough understanding of the barriers and facilitators of ART…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System by Lyimo, R.A, Boogaard, J. van den, Msoka, E, Hospers, H.J, Ven, A.A. van der, Mushi, D, Bruin, M. de

    Published in BMC public health (09-02-2011)
    “…An often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania by van den Boogaard, Jossy, Semvua, Hadija H., van Ingen, Jakko, Mwaigwisya, Solomon, van der Laan, Tridia, van Soolingen, Dick, Kibiki, Gibson S., Boeree, Martin J., Aarnoutse, Rob E.

    Published in Journal of antimicrobial chemotherapy (01-08-2011)
    “…Objectives Fluoroquinolones are used in second-line treatment of tuberculosis (TB) and have a potential role in shortening TB treatment duration. The wide use…”
    Get full text
    Journal Article
  14. 14

    Skilled or traditional birth attendant? Choices of communities in Lukulu District, rural Zambia by van den Boogaard, Jossy, Arntzen, Bart, Chilwana, Junist, Liyungu, Martin, Mantingh, Albert, Stekelenburg, Jelle

    Published in World health & population (01-03-2008)
    “…To analyse factors that contribute to the choice of either traditional birth attendants (TBAs) or skilled birth attendants (SBAs) by inhabitants of Zambia's…”
    Get more information
    Journal Article
  15. 15

    Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients by Mtabho, Charles M, Semvua, Hadija H, van den Boogaard, Jossy, Irongo, Constantine F, Boeree, Martin J, Colbers, Angela, Burger, David M, van Crevel, Reinout, van der Ven, Andre J A M, Kibiki, Gibson S, Tostmann, Alma, Aarnoutse, Rob E

    Published in Journal of antimicrobial chemotherapy (01-12-2019)
    “…Abstract Background Diabetes mellitus (DM) is associated with poor TB treatment outcome. Previous studies examining the effect of DM on TB drug concentrations…”
    Get full text
    Journal Article
  16. 16

    Therapeutic drug monitoring in the treatment of tuberculosis patients by Magis-Escurra, Cecile, van den Boogaard, Jossy, IJdema, Dirk, Boeree, Martin, Aarnoutse, Rob

    Published in Pulmonary pharmacology & therapeutics (01-02-2012)
    “…Abstract At the University Centre for Chronic Diseases Dekkerswald, a tertiary tuberculosis (TB) referral hospital in The Netherlands, therapeutic drug…”
    Get full text
    Journal Article
  17. 17

    Out-of-season increase of puerperal fever with group A Streptococcus infection: a case-control study, Netherlands, July to August 2018 by van den Boogaard, Jossy, Hahné, Susan Jm, Te Wierik, Margreet Jm, Knol, Mirjam J, Balasegaram, Sooria, de Gier, Brechje

    “…We observed an increase in notifications of puerperal group A (GAS) infections in July and August 2018 throughout the Netherlands without evidence for common…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting by de Sumari-de Boer, I. Marion, van den Boogaard, Jossy, Ngowi, Kennedy M., Semvua, Hadija H., Kiwango, Krisanta W., Aarnoutse, Rob E., Nieuwkerk, Pythia T., Kibiki, Gibson S.

    Published in AIDS and behavior (01-05-2016)
    “…HIV infected and tuberculosis (TB) patients need high levels of treatment adherence to achieve optimal treatment outcomes. We conducted a pilot-study on real…”
    Get full text
    Journal Article
  20. 20

    The complexity of the adherence‐response relationship in tuberculosis treatment: why are we still in the dark and how can we get out? by van den Boogaard, Jossy, Boeree, Martin J., Kibiki, Gibson S., Aarnoutse, Rob E.

    Published in Tropical medicine & international health (01-06-2011)
    “…Summary Non‐adherence to tuberculosis (TB) treatment is a major challenge to global TB control because it increases the risk of treatment failure, relapse and…”
    Get full text
    Journal Article